CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

FENCFENNEC PHARMACEUTICALS INC.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $10.65 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Cioffi Christiana Marie (Chief Strategy Officer) · OTHER
  • 2026-10-01 · Evans Terry L (Chief Commercial Officer) · OTHER
  • 2026-10-01 · Sayad Pierre Sargis (Chief Medical Officer) · OTHER
  • 2026-10-01 · Hackman Jeffrey S. (Chief Executive Officer) · OTHER
  • 2026-10-01 · Andrade Robert (CHIEF FINANCIAL OFFICER) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders113
Shares held21,018,054
Value$205.11M
Percent of shares outstanding59.94%
As of quarter end2026-06-30
RECENT NEWS
  • Fennec Pharmaceuticals' Pedmark met primary endpoint in Phase 2 study
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS